GE Healthcare on Wednesday announced that it has received FDA approval for its mobile mammography screening device, Reuters reports. The device will make it easier to increase screening for breast cancer in rural areas, Reuters reports (Reuters, 8/22). According to a GE release, the Senographe Essential device will improve access to mammography screening worldwide (GE release, 8/22). According to a study published in the June 15 issue of the journal Cancer, the proportion of U.S. women age 40 and older who said they have undergone a mammogram in the previous two years declined from 70% to 66% from 2000 to 2005 (Kaiser Daily Women's Health Policy Report, 5/14).

GE Healthcare Announces FDA Approval For Mobile Mammography Screening Device


Post a Comment

Google Analytics Alternative